Novartis splits drugs business into two

David Epstein, Division Head and Chief Executive, Novartis Pharmaceuticals to leave the company Novartis is splitting its pharmaceuticals division into…

CCI clears SRF, DuPont deal

The consideration for the transaction is $20 million payable in cash Diversified firm SRF has got fair trade regulator Competition…